Programmed Cascade Polydopamine Nanoclusters for Pyroptosis‐Based Tumor Immunotherapy
Small · 2024
DOI: 10.1002/smll.202401397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Zeyu Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Implantology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China. Hauptthemen laut MEDLINE: Polymers, Indoles, Immunotherapy, Pyroptosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Clinical Medicine + X Research Foundation, Youth Scientific Research Foundation, Applied Basic Research Fund of Qingdao.
Abstract (Originalsprache)
Pyroptosis, an inflammatory cell death, plays a pivotal role in activating inflammatory response, reversing immunosuppression and enhancing anti‐tumor immunity. However, challenges remain regarding how to induce pyroptosis efficiently and precisely in tumor cells to amplify anti‐tumor immunotherapy. Herein, a pH‐responsive polydopamine (PDA) nanocluster, perfluorocarbon (PFC)@octo‐arginine (R 8 )‐1‐Hexadecylamine (He)‐porphyrin (Por)@PDA‐gambogic acid (GA)‐cRGD (R‐P@PDA‐GC), is rationally design to augment phototherapy‐induced pyroptosis and boost anti‐tumor immunity through a two‐input programmed cascade therapy. Briefly, oxygen doner PFC is encapsulated within R 8 linked photosensitizer Por and He micelles as the core, followed by incorporation of GA and cRGD peptides modified PDA shell, yielding the ultimate R‐P@PDA‐GC nanoplatforms (NPs). The pH‐responsive NPs effectively alleviate hypoxia by delivering oxygen via PFC and mitigate heat resistance in tumor cells through GA. Upon two‐input programmed irradiation, R‐P@PDA‐GC NPs significantly enhance reactive oxygen species production within tumor cells, triggering pyroptosis via the Caspase‐1/GSDMD pathway and releasing numerous inflammatory factors into the TME. This leads to the maturation of dendritic cells, robust infiltration of cytotoxic CD8 + T and NK cells, and diminution of immune suppressor Treg cells, thereby amplifying anti‐tumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Implantology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
- Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266021, China.
- Precision Research Center for Refractory Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
- Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital, Sichuan University, Chengdu, 610041, China.
ORCID-Profile: Fan Li
Förderung
- Clinical Medicine + X Research Foundation
- Youth Scientific Research Foundation
- Applied Basic Research Fund of Qingdao
- Natural Science Foundation of Shandong Province
Zitieren
APA
Han, Z., Liang, Y., Li, Y., Yuan, M., Zhan, X., Yan, J., Sun, Y., Luo, K., Zhao, B., & Li, F. (2024). Programmed Cascade Polydopamine Nanoclusters for Pyroptosis‐Based Tumor Immunotherapy. Small. https://doi.org/10.1002/smll.202401397
Vancouver
Han Z, Liang Y, Li Y, Yuan M, Zhan X, Yan J, et al. Programmed Cascade Polydopamine Nanoclusters for Pyroptosis‐Based Tumor Immunotherapy. Small. 2024. doi:10.1002/smll.202401397
BibTeX
@article{Han2024,
author = {Han, Zeyu and Liang, Yan and Li, Yan and Yuan, Mujie and Zhan, Xin and Yan, Jianqin and Sun, Yong and Luo, Kui and Zhao, Baodong and Li, Fan},
title = {Programmed Cascade Polydopamine Nanoclusters for Pyroptosis‐Based Tumor Immunotherapy},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202401397}
}
EUVIMED